Negative regulation of the RIG-I signaling by the ubiquitin ligase RNF125
暂无分享,去创建一个
Hideyuki Konishi | K. Shimotohno | T. Fujita | K. Arimoto | Takayuki Hishiki | Kunitada Shimotohno | H. Konishi | Kei-ichiro Arimoto | Hitoshi Takahashi | Takayuki Hishiki | Takashi Fujita | Hitoshi Takahashi
[1] O. Jänne,et al. PIAS Proteins Modulate Transcription Factors by Functioning as SUMO-1 Ligases , 2002, Molecular and Cellular Biology.
[2] Hong-Bing Shu,et al. A20 is a potent inhibitor of TLR3‐ and Sendai virus‐induced activation of NF‐κB and ISRE and IFN‐β promoter , 2004 .
[3] Osamu Takeuchi,et al. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction , 2005, Nature Immunology.
[4] P. Howley,et al. Physical Interaction between Specific E2 and Hect E3 Enzymes Determines Functional Cooperativity* , 1997, The Journal of Biological Chemistry.
[5] R. Krug,et al. The UbcH8 ubiquitin E2 enzyme is also the E2 enzyme for ISG15, an IFN-α/β-induced ubiquitin-like protein , 2004 .
[6] David C Schwartz,et al. A superfamily of protein tags: ubiquitin, SUMO and related modifiers. , 2003, Trends in biochemical sciences.
[7] S. Akira,et al. Toll-like receptors in innate immunity. , 2004, International immunology.
[8] S. Goodbourn,et al. The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[9] S. Akira,et al. Toll-like receptors. , 2003, Annual review of immunology.
[10] R. Ulevitch,et al. Triad3A, an E3 ubiquitin-protein ligase regulating Toll-like receptors , 2004, Nature Immunology.
[11] Qiang Sun,et al. Negative Regulation of the Retinoic Acid-inducible Gene I-induced Antiviral State by the Ubiquitin-editing Protein A20* , 2006, Journal of Biological Chemistry.
[12] Shizuo Akira,et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses , 2004, Nature Immunology.
[13] T. Dawson,et al. Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[14] D. Payan,et al. A Novel E3 Ubiquitin Ligase TRAC-1 Positively Regulates T Cell Activation , 2005, The Journal of Immunology.
[15] M. Scheffner,et al. The Ubiquitin-conjugating Enzymes UbcH7 and UbcH8 Interact with RING Finger/IBR Motif-containing Domains of HHARI and H7-AP1* , 1999, The Journal of Biological Chemistry.
[16] D. Tough,et al. Links between innate and adaptive immunity via type I interferon. , 2002, Current opinion in immunology.
[17] C. Janeway,et al. Innate immune recognition. , 2002, Annual review of immunology.
[18] Kenji Nakanishi,et al. SOCS-1 participates in negative regulation of LPS responses. , 2002, Immunity.
[19] G. Sobue,et al. A novel centrosomal ring-finger protein, dorfin, mediates ubiquitin ligase activity. , 2001, Biochemical and biophysical research communications.
[20] S. Lemon,et al. Regulating Intracellular Antiviral Defense and Permissiveness to Hepatitis C Virus RNA Replication through a Cellular RNA Helicase, RIG-I , 2005, Journal of Virology.
[21] R. Krug,et al. Herc5, an Interferon-induced HECT E3 Enzyme, Is Required for Conjugation of ISG15 in Human Cells* , 2006, Journal of Biological Chemistry.
[22] M. Sweet,et al. A Novel Pathway Regulating Lipopolysaccharide-Induced Shock by ST2/T1 Via Inhibition of Toll-Like Receptor 4 Expression1 , 2001, The Journal of Immunology.
[23] Steven Gygi,et al. Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[24] B. Beutler,et al. TYPE I INTERFERONS (/) IN IMMUNITY AND AUTOIMMUNITY , 2005 .
[25] E. Borden,et al. High-throughput Immunoblotting , 2003, The Journal of Biological Chemistry.
[26] S. Akira,et al. Toll-like receptors: critical proteins linking innate and acquired immunity , 2001, Nature Immunology.
[27] J. Vavalle,et al. Staring, a Novel E3 Ubiquitin-Protein Ligase That Targets Syntaxin 1 for Degradation* , 2002, The Journal of Biological Chemistry.
[28] N. Hattori,et al. Parkin is linked to the ubiquitin pathway , 2001, Journal of Molecular Medicine.
[29] Zhijian J. Chen,et al. Identification and Characterization of MAVS, a Mitochondrial Antiviral Signaling Protein that Activates NF-κB and IRF3 , 2005, Cell.
[30] Yoko Takahashi,et al. Ezrin-radixin-moesin (ERM)-binding phosphoprotein 50 organizes ERM proteins at the apical membrane of polarized epithelia. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[31] Satoshi Inoue,et al. Efp targets 14-3-3σ for proteolysis and promotes breast tumour growth , 2002, Nature.
[32] A. Iwasaki,et al. Toll-like receptor control of the adaptive immune responses , 2004, Nature Immunology.
[33] Ralf Bartenschlager,et al. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus , 2005, Nature.
[34] C. Janeway,et al. Innate Immunity: The Virtues of a Nonclonal System of Recognition , 1997, Cell.
[35] Osamu Takeuchi,et al. Cell type-specific involvement of RIG-I in antiviral response. , 2005, Immunity.